Review Article
Phoenix Dactylifera (Dates) as a Non-pharmaceutical Traditional Food for Expectant and Lactating Mothers: Implications for Reproductive Health
Issue:
Volume 14, Issue 1, February 2026
Pages:
1-10
Received:
24 September 2025
Accepted:
8 November 2025
Published:
4 February 2026
Abstract: Date palm is known to be the oldest plant in the world. Both fruit and seeds are packed with powerful nutritious and therapeutic properties. Important in Muslim community due to mentioned in Quran and Hadith for its therapeutic and healing properties in reproductive age, which proved by Modern scientific studies for both fetus, infant, and mother. Play crucial role to increased energy stores for delivery, high content of potassium act as a vasodilator and presence of angiotensin-converting enzyme inhibitor and reduce risk of preeclampsia and eclampsia, promote breastmilk production during lactation. Rich bioactive profile acts as an antioxidant and suppresses oxidative damage and boosts up fertility as well as enhance immune response by increasing count of WBC and Nk cell. In short dates fruit might be considered one of the complete nutritional foods to fulfil the requirements of reproductive health. This review highlighted pharmacological and nutraceutical properties of dates fruit and its potential use as a non-pharmacological traditional medicine in reducing pregnancy, lactation, and infertility consequences.
Abstract: Date palm is known to be the oldest plant in the world. Both fruit and seeds are packed with powerful nutritious and therapeutic properties. Important in Muslim community due to mentioned in Quran and Hadith for its therapeutic and healing properties in reproductive age, which proved by Modern scientific studies for both fetus, infant, and mother. ...
Show More
Research Article
Obstetric Morbidity and Mortality Associated with Antiphospholipid Syndrome: A Study Conducted in Tivaouane, Senegal
Bachir Mansour Diallo*
,
Khalifa Fall,
Aboubakry Sow,
Adama Wade,
Abo Ibrahima Thiam,
Mafing Aya Sylla,
Stephane Bacourine,
Haolatou Gano,
Aicha Kaneye,
Aminata Dia Gueye,
Yanidou Ndiaye,
Adama Berthe,
Papa Souleymane Toure,
Madoky Magatte Diop,
Mamadou Mourtalla Ka
Issue:
Volume 14, Issue 1, February 2026
Pages:
11-17
Received:
14 January 2026
Accepted:
27 January 2026
Published:
23 March 2026
DOI:
10.11648/j.ajim.20261401.12
Downloads:
Views:
Abstract: Introduction: Antiphospholipid antibody syndrome (APS) is a condition that can affect obstetric prognosis. We conducted a study to determine the frequency of this condition in our hospital. Materials and methods: This was a prospective cross-sectional study conducted in the internal medicine department of Abdou Aziz Sy Hospital. We included all patients who had arguments in favor of APS. Results: We included 19 patients. The average age was 32 years, with extremes of 31 and 42 years. The average duration of the condition was 6.7 years, with extremes of 1 and 10 years. The average number of pregnancies was 5.79, ranging from 4 to 14 pregnancies. Obstetric manifestations included abortions (in all patients), retained dead fetuses in 3 patients, and intrauterine fetal death in 3 patients. Extra-gynecological and obstetric signs included inflammatory polyarthralgia (in 6 patients), erythematosquamous lesions (4 patients), and physical asthenia (4 patients). Antinuclear antibodies were positive in 13 patients, and anti-ECT antibodies were positive in 7 patients. Circulating lupus anticoagulant was found in 6 patients, anticardiolipin in 7 patients, and anti-glycoprotein I in 5 patients. APS was primary in 10 patients and seronegative in 2 patients. Abortions were more closely correlated with the presence of circulating lupus anticoagulant and the co-occurrence of antibodies. Treatment consisted of conventional immunosuppressants in patients monitored for secondary APS and curative heparin therapy in six patients who became pregnant during follow-up, with a favorable outcome in three patients. Conclusion: APS is an underdiagnosed condition with a serious obstetric prognosis that compromises the maternal-fetal prognosis.
Abstract: Introduction: Antiphospholipid antibody syndrome (APS) is a condition that can affect obstetric prognosis. We conducted a study to determine the frequency of this condition in our hospital. Materials and methods: This was a prospective cross-sectional study conducted in the internal medicine department of Abdou Aziz Sy Hospital. We included all pat...
Show More
